logo image
search icon
Global Veterinary Infectious Disease Diagnostics Market

Veterinary Infectious Disease Diagnostics Market Size, Share & Trends Analysis Report By Technology (Immunodiagnostics, Molecular diagnostic, Other technology), By Animal Type, By End-User, By Region, And Segment Forecasts, 2024-2031

Report ID : 1488 | Published : 2024-03-14 | Pages: 188 | Format: PDF/EXCEL

The Global Veterinary Infectious Disease Diagnostics Market Size is valued at USD 2.06 billion in 2023 and is predicted to reach USD 3.95 billion by the year 2031 at an 8.69% CAGR during the forecast period for 2024-2031.

Key Industry Insights & Findings from the Report:

  • The veterinary infectious disease diagnostics market is poised to capitalize on significant potential presented by growing demand from developing nations and the increasing number of vegans.
  • Rising spending on animal health care and the number of pets owned are the main forces propelling the Veterinary Infectious Disease Diagnostics Market worldwide.
  • North America dominated the market and accounted for a revenue share of global revenue in 2023.
  • The shortage of veterinary professionals in developing nations poses the greatest threat to the forecasted expansion of the market.

veterinary infectious

Tests that assist in determining and identifying various animal illnesses are known as veterinary infectious disease diagnostics. These treatments are carried out using different techniques using tissue, excrement, and patient blood samples. Some of the factors that have led to the growth of this business include the prevalence of zoonotic diseases, the price of animal health, the number of veterinarians, the development of point-of-care diagnostics, and the level of discretionary money in emerging nations.

Veterinary infectious illnesses are the major sickness category in terms of market size. Animal diagnosis has a positive outlook, which promotes an increase in the species' population. The increasing prevalence of companion animals in households and farms will result in favourable market growth for the forecast period. Expanding research collaborations, growing research facilities, and growing direct and indirect research investments will increase the demand for the product.

The demand for pet insurance is rising, there is an increase in the number of companion animals, and there is an increase in the number of modern diagnostic tools for animals; as more companion animals contract various infectious diseases, the veterinary infectious disease diagnostics market is expanding. The development of the veterinary infectious disease diagnostics industry is, however, constrained by a need for more knowledge regarding using these instruments in less developed nations. The veterinary contagious disease diagnostics market will expand during the forecast mentioned above due to rising applications from emerging economies and increasing vegan trends, which will also present enormous opportunities.

Competitive Landscape

Some major key players in the Global Veterinary Infectious Disease Diagnostics Market:

  • IDEXX Laboratories, Inc. (US),
  • ZOetis, Inc. (US),
  • Thermo Fisher Scientific, Inc. (US),
  • Virbac(France),
  • bioMerieux SA (France)
  • Heska Corporation (US),
  • Idvet (France),
  • NEOGEN Corporation (US),
  • QIAGEN N.V. (a part of INDICAL Biosicence) (Europe),
  • Randoxz Laboratories Ltd. (UK),
  • Agrolabo S.pA. (Italy),
  • Bio-Rad Laboratories (US),
  • Bionote, Inc.(South Korea),
  • Biogal Galed Labs (Isreal),
  • BioChek (Netherlands),(UK)
  • Biopanda Regrants(UK),
  • URIT Medical Electric Co.Ltd. (China),
  • MEGACOR Diagnostik GmbH (Germany),
  • Fassisi GmbH (Germany),
  • Alvedia (France),
  • SKYER, Inc. (South Korea),
  • Shenzhen Bioeasy Biotechnology Co., Ltd. (China) ,
  • Precision Biosensor (US).

Market Segmentation:

The veterinary infectious disease diagnostics market is divided into technology, animal type,  and end-use. Based on technology, the veterinary infectious disease diagnostics market is segmented into immunodiagnostics (lateral flow assays, elisa tests, other immunodiagnostics products), molecular diagnostic (polymerase chain reaction (PCR) tests, microarrays, other molecular diagnostic products) and other technologies. Based on animal type, the veterinary infectious disease diagnostics market is segmented into companion animals (cats, dogs, horses, other companion animals), companion animals by infection type (viral infections, bacterial infections, parasitic infections, other infections), food-producing animals (cattle, pigs, poultry, other food-producing animals) and food-producing animals, by infection type (viral infections, bacterial infections, parasitic infections, other infections). The veterinary infectious disease diagnostics market is divided into reference laboratories, veterinary hospitals and clinics, point-of-care/in-house testing, research institutes and universities.

Based on product, the immunoassays segment is a major contributor to the veterinary infectious disease diagnostics market.

The market's leading segment is immunoassays. The growing use of immunoassays in the diagnosis of infectious diseases, the creation of novel tests, the rising trend of automation, the rise in public awareness of fitness and health, and the decreased complications caused by the instruments are the fundamental causes of this market's domination. However, antibody and antigen detection by immunoassays is the primary method by which the infection is established in some infectious disorders, such as Lyme disease, cryptococcal meningitis, and syphilis. Immunoassays are increasingly available for point-of-care testing due to their simplicity, quick turnaround time, and generally excellent specificity. These elements will cause the market to see expansion throughout the anticipated timeframe.

The reference laboratories segment witnessed growth at a rapid rate.

Reference laboratories grabbed the highest revenue share, and it is anticipated that they will continue to hold that position during the anticipated time. The enormous number of samples from small and large animal practices sent to reference laboratories for analysis may cause a significant share of this end-user category. The healthcare sector's increased production of medical samples and developments in some medical specialties, including hematology and serology, is anticipated to be the primary growth drivers for the clinical reference laboratory services market. Another significant growth driver for the clinical reference laboratory services has been the research and advanced studies carried out in cytogenetics, tumors, and human genomes, all of which are fundamental components of the broader microbiology field.

The North American veterinary infectious disease diagnostics market holds a significant regional revenue share.

The North American veterinary infectious disease diagnostics market is expected to register the highest market share. The cost increase demonstrates owners' desire to take their pets for diagnostic tests. These elements will cause the market to expand significantly in the future years. Due to the rapid adoption of pets, rising spending on animal health, the availability of advanced diagnostic technologies and favorable pet insurance coverage, the prevalence of major market players, and the rise in zoonotic diseases, the U.S. currently dominates the global market for veterinary infectious disease diagnostics. This trend is expected to continue during the forecast period. Besides, Asia pacific region is estimated to hold a significant market share. The region's market is expanding due to increasing zoonotic disease occurrences and rising demand for diagnostics for infectious diseases. Owners' desire to take their dogs for diagnostic tests is evident in the cost increase. The market will grow significantly in the coming years due to these factors. Additionally, the expansion of the regional market as a whole is being greatly aided by an increase in R&D activities and a good healthcare infrastructure.

Recent Developments:

  • In January 2024, IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, unveiled the IDEXX in Vue DxTM Cellular Analyzer. This revolutionary device is the first of its kind and can diagnose the most common cytologic abnormalities found in blood and ear samples.
  • In January 2024, Neogen Corporation introduced the SureKill Gel Bait Pro Applicator, the newest SureKill line of pest control solutions member.
  • In June 2023, Chembio Diagnostics, Inc., a front-runner in infectious disease point-of-care diagnostics, announced that it had received a Clinical Laboratory Improvement Amendments (CLIA) waiver for the DPP HIV-Syphilis System from the U.S. Food and Drug Administration (FDA).

Global Veterinary Infectious Disease Diagnostics Market Report Scope

 

Report Attribute

Specifications

Market Size Value In 2023

USD 2.06 billion

Revenue Forecast In 2031

USD 3.95 billion

Growth Rate CAGR

CAGR of 8.69% from 2024 to 2031

Quantitative Units

Representation of revenue in US$ illion and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

Technology, Animal Type, End-User

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

IDEXX Laboratories, Inc. (US), ZOetis, Inc. (US), Thermo Fisher Scientific, Inc. (US), Virbac (France), bioMerieux SA (France) Heska Corporation (US), Idvet (France), NEOGEN Corporation (US), QIAGEN N.V. (a part of INDICAL Biosicence) (Europe), Randoxz Laboratories Ltd. (UK), Agrolabo S.pA. (Italy), Bio-Rad Laboratories (US), Bionote, Inc. (South Korea), Biogal Galed Labs (Isreal), BioChek (Netherlands),(UK) Biopanda Regrants (UK), URIT Medical Electric Co.Ltd. (China), MEGACOR Diagnostik GmbH (Germany), Fassisi GmbH (Germany), Alvedia (France), SKYER, Inc. (South Korea), Shenzhen Bioeasy Biotechnology Co., Ltd. (China) , and Precision Biosensor (US).

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Veterinary Infectious Disease Diagnostics Market Snapshot

Chapter 4. Global Veterinary Infectious Disease Diagnostics Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Technology Estimates & Trend Analysis

5.1. by Technology & Market Share, 2019 & 2031

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Technology:

5.2.1. Immunodiagnostics

5.2.1.1. Lateral Flow Assays

5.2.1.2. ELISA Test

5.2.1.3. Other Immunodiagnostics Products

5.2.2. Molecular Diagnostic

5.2.2.1. Polymerase Chain Reaction (PCR) Tests

5.2.2.2. Microarrays

5.2.2.3. Other Molecular Diagnostic Products

5.2.3. Other Technologies

Chapter 6. Market Segmentation 2: by Animal Type Estimates & Trend Analysis

6.1. by Animal Type & Market Share, 2019 & 2031

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Animal Type:

6.2.1. Companion Animals

6.2.1.1. Cats

6.2.1.2. Dogs

6.2.1.3. Horses

6.2.1.4. Other Companion Animals

6.2.2. Companion Animals By Infection Type

6.2.2.1. Viral Infections

6.2.2.2. Bacterial Infections

6.2.2.3. Parasitic Infections

6.2.2.4. Other Infections

6.2.3. Food -producing Animals

6.2.3.1. Cattle

6.2.3.2. Pigs

6.2.3.3. Poultry

6.2.3.4. Other Food-producing animals

6.2.4. Food-producing Animals, By Infection Type

6.2.4.1. Viral Infections

6.2.4.2. Bacterial Infections

6.2.4.3. Parasitic Infections

6.2.5. Other Infections

Chapter 7. Market Segmentation 3: by End-user Estimates & Trend Analysis

7.1. by End-user & Market Share, 2019 & 2031

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-user:

7.2.1. Reference Laboratories

7.2.2. Veterinary Hospitals and Clinics

7.2.3. Point-of-care/ In-house testing

7.2.4. Research Institutes and Universities

Chapter 8. Veterinary Infectious Disease Diagnostics Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031

8.1.2. North America Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031

8.1.3. North America Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031

8.1.4. North America Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

8.2. Europe

8.2.1. Europe Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031

8.2.2. Europe Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031

8.2.3. Europe Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031

8.2.4. Europe Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

8.3. Asia Pacific

8.3.1. Asia Pacific Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031

8.3.2. Asia Pacific Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031

8.3.3. Asia-Pacific Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031

8.3.4. Asia Pacific Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

8.4. Latin America

8.4.1. Latin America Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031

8.4.2. Latin America Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031

8.4.3. Latin America Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031

8.4.4. Latin America Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

8.5. Middle East & Africa

8.5.1. Middle East & Africa Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031

8.5.2. Middle East & Africa Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031

8.5.3. Middle East & Africa Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031

8.5.4. Middle East & Africa Veterinary Infectious Disease Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. IDEXX Laboratories, Inc. (US)

9.2.2. ZOetis, Inc. (US)

9.2.3. Thermo Fisher Scientific, Inc. (US)

9.2.4. Virbac (France)

9.2.5. bioMerieux SA (France) Heska Corporation (US)

9.2.6. Idvet (France)

9.2.7. NEOGEN Corporation (US)

9.2.8. QIAGEN N.V. (a part of INDICAL Biosicence) (Europe)

9.2.9. Randoxz Laboratories Ltd. (UK),

9.2.10. Agrolabo S.pA. (Italy)

9.2.11. Bio-Rad Laboratories (US)

9.2.12. Bionote, Inc. (South Korea)

9.2.13. Biogal Galed Labs (Isreal)

9.2.14. BioChek (Netherlands)(UK Biopanda Regrants (UK)

9.2.15. URIT Medical Electric Co.Ltd. (China)

9.2.16. MEGACOR Diagnostik GmbH (Germany)

9.2.17. Fassisi GmbH (Germany)

9.2.18. Alvedia (France)

9.2.19. SKYER, Inc. (South Korea)

9.2.20. Shenzhen Bioeasy Biotechnology Co., Ltd. (China)

9.2.21. Precision Biosensor (US)

9.2.22. Other Prominent Players

 

Segmentation of Veterinary Infectious Disease Diagnostics

By Technology

  • Immunodiagnostics
    • Lateral Flow Assays
    • ELISA Test
    • Other Immunodiagnostics Products
  • Molecular Diagnotic
    • Polymerase Chain Reaction (PCR) Tests
    • Microarrays
    • Other Molecular Diagnostic Products
  • Other Technologies

veterinary infectious

By Animal Type

  • Companion Animals
    • Cats
    • Dogs
    • Horses
    • Other Companion Animals
  • Companion Animals By Infection Type
    • Viral Infections
    • Bacterial Infections
    • Parasitic Infections
    • Other Infections
  • Food -producing Animals
    • Cattle
    • Pigs
    • Poultry
    • Other Food-producing animals
  • Food-producing Animals, By Infection Type
    • Viral Infections
    • Bacterial Infections
    • Parasitic Infections
    • Other Infections

By End User

  • Reference Laboratories
  • Veterinary Hospitals and Clincs
  • Point-of-care/ In-house testing
  • Research Institutes and Universities

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How Big is the Veterinary Infectious Disease Diagnostics Market ?

The Global Veterinary Infectious Disease Diagnostics Market is expected to grow at an 8.69% CAGR during the forecast period for 2024-2031.

IDEXX Laboratories, Inc. (US), ZOetis, Inc. (US), Thermo Fisher Scientific, Inc. (US), Virbac (France), bioMerieux SA (France) Heska Corporation (US),

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Veterinary

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach